Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Michael P. Shea"'
Autor:
Kathleen A. O'Leary, Michael P. Shea, Stephanie Salituro, Courtney E. Blohm, Linda A. Schuler
Publikováno v:
Stem Cell Reports, Vol 9, Iss 4, Pp 1167-1179 (2017)
Hormones drive mammary development and function and play critical roles in breast cancer. Epidemiologic studies link prolactin (PRL) to increased risk for aggressive cancers that express estrogen receptor α (ERα). However, in contrast to ovarian st
Externí odkaz:
https://doaj.org/article/71a50e29243b4b40beb7917e2dbc3d90
Autor:
Barnabas G. Williams, Lloyd D. W. King, David Pulido, Doris Quinkert, Amelia M. Lias, Sarah E. Silk, Robert J. Ragotte, Hannah Davies, Jordan R. Barrett, Kirsty McHugh, Cassandra A. Rigby, Daniel G. W. Alanine, Lea Barfod, Michael W. Shea, Li An Cowley, Rebecca A. Dabbs, David J. Pattinson, Alexander D. Douglas, Oliver R. Lyth, Joseph J. Illingworth, Jing Jin, Cecilia Carnrot, Vinayaka Kotraiah, Jayne M. Christen, Amy R. Noe, Randall S. MacGill, C. Richter King, Ashley J. Birkett, Lorraine A. Soisson, Katherine Skinner, Kazutoyo Miura, Carole A. Long, Matthew K. Higgins, Simon J. Draper
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Reticulocyte-binding protein homologue 5 (RH5), a leading blood-stage Plasmodium falciparum malaria vaccine target, interacts with cysteine-rich protective antigen (CyRPA) and RH5-interacting protein (RIPR) to form an essential heterotrimeri
Externí odkaz:
https://doaj.org/article/c0357f954cd04ff984155d03439a386e
Publikováno v:
Journal of Youth Development, Vol 1, Iss 2, Pp 65-77 (2006)
This article provides background on the SMARTRISK Heroes Program, a mobile stage production that introduces young people to the prevalence of unintentional injury for their age group and presents them with a series of strategies that will reduce the
Externí odkaz:
https://doaj.org/article/2ade435c15a34a078741e756dbfdb5b9
Autor:
Christopher K. Mason, Sara K. Adie, Michael J. Shea, Matthew C. Konerman, Michael P. Thomas, Jakob I. McSparron, Theodore J. Iwashyna, Hallie C. Prescott, Andrea D. Thompson
Publikováno v:
American Heart Journal Plus, Vol 38, Iss , Pp 100363- (2024)
Objective: Patients who survive critical illness endure complex physical and mental health conditions, referred to as post-intensive care syndrome (PICS). The University of Michigan's post-intensive cardiac care outpatient long-term outreach (PICCOLO
Externí odkaz:
https://doaj.org/article/b4485879e19e4070973a180acf608ace
Autor:
Linda A. Schuler, Caroline M. Alexander, Kari B. Wisinski, Andreas Friedl, Vincent Goffin, Saja A. Fakhraldeen, Kathleen A. O'Leary, Michael P. Shea
Supplemental Tables 1 and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a528479488284c5962d2cd068ae4e0e8
https://doi.org/10.1158/0008-5472.22417473.v1
https://doi.org/10.1158/0008-5472.22417473.v1
Autor:
Linda A. Schuler, Caroline M. Alexander, Kari B. Wisinski, Andreas Friedl, Vincent Goffin, Saja A. Fakhraldeen, Kathleen A. O'Leary, Michael P. Shea
This file contains additional technical detail (antibodies used, gating strategy for FACS) and additional experimental data to complement that shown in the main figures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab7daad44b16300298a01e28c05aeffd
https://doi.org/10.1158/0008-5472.22417476.v1
https://doi.org/10.1158/0008-5472.22417476.v1
Autor:
Linda A. Schuler, Caroline M. Alexander, Kari B. Wisinski, Andreas Friedl, Vincent Goffin, Saja A. Fakhraldeen, Kathleen A. O'Leary, Michael P. Shea
Although antiestrogen therapies are successful in many patients with estrogen receptor alpha-positive (ERα+) breast cancer, 25% to 40% fail to respond. Although multiple mechanisms underlie evasion of these treatments, including tumor heterogeneity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b44379cf0495053845583fdfbf888e
https://doi.org/10.1158/0008-5472.c.6509853.v1
https://doi.org/10.1158/0008-5472.c.6509853.v1
Publikováno v:
Cancer Letters. 433:1-9
Metastatic estrogen receptor alpha positive (ERα+) cancers account for most breast cancer mortality. Cancer stem cells (CSCs) and dense/stiff extracellular matrices are implicated in aggression and therapy resistance. We examined this interplay and
Autor:
Linda A. Schuler, Debra E. Rugowski, Ruth Sullivan, Michael P. Shea, Kathleen A. O'Leary, Amy R. Moser
Publikováno v:
Cancer Lett
Prolactin (PRL) cooperates with other factors to orchestrate mammary development and lactation, and is epidemiologically linked to higher risk for breast cancer. However, how PRL collaborates with oncogenes to foster tumorigenesis and influence breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b0a32e9696980071fedd2010520f542
https://europepmc.org/articles/PMC7995738/
https://europepmc.org/articles/PMC7995738/
Autor:
Saja A. Fakhraldeen, Kathleen A. O'Leary, Andreas Friedl, Caroline M. Alexander, Vincent Goffin, Michael P. Shea, Kari B. Wisinski, Linda A. Schuler
Publikováno v:
Cancer Research. 78:1672-1684
Although antiestrogen therapies are successful in many patients with estrogen receptor alpha-positive (ERα+) breast cancer, 25% to 40% fail to respond. Although multiple mechanisms underlie evasion of these treatments, including tumor heterogeneity